CN107205956A - 输送系统 - Google Patents

输送系统 Download PDF

Info

Publication number
CN107205956A
CN107205956A CN201580059236.5A CN201580059236A CN107205956A CN 107205956 A CN107205956 A CN 107205956A CN 201580059236 A CN201580059236 A CN 201580059236A CN 107205956 A CN107205956 A CN 107205956A
Authority
CN
China
Prior art keywords
yarn
coating
segments
delivery system
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580059236.5A
Other languages
English (en)
Chinese (zh)
Inventor
戴维·安德森
乔丹·辛德勒
埃里克·斯科特·戈贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Textile Technology Ltd By Share Ltd
Original Assignee
Textile Technology Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Textile Technology Ltd By Share Ltd filed Critical Textile Technology Ltd By Share Ltd
Publication of CN107205956A publication Critical patent/CN107205956A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201580059236.5A 2014-10-30 2015-10-29 输送系统 Pending CN107205956A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072896P 2014-10-30 2014-10-30
US62/072,896 2014-10-30
PCT/US2015/058059 WO2016069898A1 (en) 2014-10-30 2015-10-29 Delivery systems

Publications (1)

Publication Number Publication Date
CN107205956A true CN107205956A (zh) 2017-09-26

Family

ID=55851473

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580059236.5A Pending CN107205956A (zh) 2014-10-30 2015-10-29 输送系统

Country Status (10)

Country Link
US (7) US9669012B2 (https=)
EP (1) EP3212173A4 (https=)
JP (1) JP6896625B2 (https=)
KR (1) KR20170076756A (https=)
CN (1) CN107205956A (https=)
AU (1) AU2015339203B2 (https=)
BR (1) BR112017007942A2 (https=)
CA (1) CA3003397A1 (https=)
MX (1) MX2017005399A (https=)
WO (1) WO2016069898A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114045587A (zh) * 2021-11-10 2022-02-15 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
CN114959966A (zh) * 2022-07-15 2022-08-30 苏州赛恩环境科技有限公司 一种内注甲醛清除剂的纤维线生产设备及方法
EP4084607A4 (en) * 2019-12-31 2023-06-21 Wanka Tanka Ltd. EXTENDED RELEASE PLASTIC FORMULATION

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014160744A1 (en) * 2013-03-26 2014-10-02 Innovia Llc Pacemaker lead and other medical implant devices
KR20170076756A (ko) 2014-10-30 2017-07-04 텍스타일-베이스드 딜리버리, 인코포레이티드 전달 시스템
US11690928B2 (en) * 2017-07-17 2023-07-04 Peter Rigg Fragrance delivery systems
WO2019094546A1 (en) * 2017-11-13 2019-05-16 Casey Nicole Warp yarn of woven textiles
CN112739322B (zh) 2018-09-18 2024-06-21 玫琳凯有限公司 减少色素沉着过度的皮肤外观或提亮皮肤的植物提取物
EP3666939B1 (en) 2018-12-12 2024-10-30 Aladdin Manufacturing Corporation A multifilament bundle of melt spun polymer filaments
US20210259985A1 (en) * 2020-02-20 2021-08-26 WeDoWee, LLC Method of providing cbd oil within polymer fibrous structures for subsequent transfer to a user's skin
IT202000005515A1 (it) * 2020-03-16 2021-09-16 U Earth Biotech Ltd Maschera filtrante perfezionata
US12473667B2 (en) 2020-06-16 2025-11-18 Aladdin Manufacturing Corporation Systems and methods to provide color enhanced yarns
EP4164974A4 (en) 2020-06-16 2025-01-08 Aladdin Manufacturing Corporation SYSTEMS AND METHODS FOR PRODUCING A FILAMENT BUNDLE AND/OR A YARN
WO2021257738A1 (en) 2020-06-16 2021-12-23 Aladdin Manufacturing Corporation Systems and methods for producing a bundle of filaments and/or a yarn
US12186512B2 (en) * 2020-10-26 2025-01-07 Christopher Green Treatment for dry eyes
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
WO2022187848A1 (en) 2021-03-05 2022-09-09 H.B. Fuller Company Cyanoacrylate composition with hazardless stabilizer
IT202100006284A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Mezzi di filtraggio di una maschera facciale indossabile
IT202100006290A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Una maschera facciale indossabile e configurata per filtrare l’aria inalata da un utente
CA3213211A1 (en) * 2021-04-23 2022-10-27 Lucinda Jones Method of manufacturing yarn and yarn obtained in that manner
WO2022238862A1 (en) * 2021-05-12 2022-11-17 Aladdin Manufacturing Corporation Fibers with active additives technical field
US20220372695A1 (en) * 2021-05-20 2022-11-24 Textile-Based Delivery, Inc. Active agent indicator for textiles
US12589176B2 (en) 2021-10-29 2026-03-31 Scentral Zone, Llc Passive emission fragrance diffuser for personal use
US12245644B2 (en) * 2022-04-28 2025-03-11 Tamika MAYES Support garments

Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674901A (en) * 1966-07-26 1972-07-04 Nat Patent Dev Corp Surgical sutures
JPS4840924B1 (https=) * 1970-09-26 1973-12-04
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
US6040251A (en) * 1988-03-14 2000-03-21 Nextec Applications Inc. Garments of barrier webs
JP2000096443A (ja) * 1998-09-25 2000-04-04 Toray Ind Inc 繊維布帛およびその製造方法
JP2000212873A (ja) * 1999-01-18 2000-08-02 Nonogawa Shoji Kk 機能性繊維
US6103644A (en) * 1993-12-22 2000-08-15 Nordico Marketing Development, Inc. Impregnated matrix and method for making same
JP2001097839A (ja) * 1999-09-28 2001-04-10 Shiseido Co Ltd 加齢臭抑制繊維および繊維処理剤
CN1378445A (zh) * 1999-08-06 2002-11-06 得克萨斯系统大学评议会 药物释放生物可降解纤维植入物
CN1520297A (zh) * 2001-04-26 2004-08-11 ���ߵ���Ƶϵͳ��˾ 包含复合药物(codrugs)的缓释药物传递系统
US20040162580A1 (en) * 2000-08-17 2004-08-19 Matthew Hain Sutures and coatings made from therapeutic absorbable glass
CN1612804A (zh) * 2001-12-03 2005-05-04 C·R·巴德公司 抗微生物医用器材、抗微生物聚合物涂层及其制备方法
CN1813085A (zh) * 2003-06-30 2006-08-02 宝洁公司 涂层纳米纤维网
CN100572651C (zh) * 2004-08-04 2009-12-23 考格尼斯知识产权管理有限责任公司 成品纤维和纺织品组织
CN101970560A (zh) * 2008-01-08 2011-02-09 奎克-麦德技术公司 醇可溶性的季铵聚合物消毒剂
CN102740830A (zh) * 2009-12-23 2012-10-17 普西维达公司 缓释递送装置
WO2013033606A1 (en) * 2011-08-31 2013-03-07 The University Of Akron Coated fibers exhibiting beads-on-a-string morphology
CN103037907A (zh) * 2010-03-31 2013-04-10 境味股份有限公司 用于嗅觉活性物质的方法、组合物和制品
WO2014031676A1 (en) * 2012-08-20 2014-02-27 O-Ray Pharma, Inc. Process for manufacturing drug delivery formulations
CN103987378A (zh) * 2011-09-09 2014-08-13 阿克西亚制药有限责任公司 硅氧烷涂覆的植入物
WO2014143866A1 (en) * 2013-03-15 2014-09-18 Arsenal Medical, Inc. Core-sheath fibers and methods of making and using same

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1814853A (en) 1930-01-13 1931-07-14 Dow Chemical Co Method of purifying methyl salicylate
US2799598A (en) 1951-08-17 1957-07-16 Owens Corning Fiberglass Corp Process of forming coated twisted yarns and woven fabrics and resultant article
US3845791A (en) 1970-10-15 1974-11-05 Continental Can Co Universal filling head
BE789524A (fr) * 1971-09-30 1973-01-15 Alza Corp Dispositif de liberation de medicaments
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
JPS6072550A (ja) * 1983-09-27 1985-04-24 日東電工株式会社 創傷カバ−剤
US5221722A (en) * 1988-11-28 1993-06-22 The B. F. Goodrich Company Crosslinked polyacrylic acid
EP0395476A3 (en) * 1989-04-28 1992-01-08 Ricoh Kyosan Inc. Method and apparatus for the production of ionic cloths for use in ionic dressings
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
US5531925A (en) 1991-10-04 1996-07-02 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
US5353820A (en) * 1992-02-06 1994-10-11 Gillette Canada Inc. Flavored dental cleaning article and method
US5299335A (en) 1993-08-23 1994-04-05 Ivester Philip K Fragrance-releasing pillow and the like
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
DE69733268T2 (de) 1996-01-30 2006-01-19 Novagent Oy Zusammensetzung für die kontrollierte Freisetzung eines Arzneimittels bei der transdermalen Verabreichung
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6020412A (en) * 1997-12-04 2000-02-01 Mitsubishi Polyester Film, Llc Controlled release coating comprising blend of silicone polymer and adhesion promoter
US5965137A (en) 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
US7033603B2 (en) 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6158253A (en) * 1999-09-17 2000-12-12 Knit-Rite, Inc. Seamless, form fitting foot sock
DE10085395T1 (de) * 1999-12-27 2002-12-05 Kimberly Clark Co Fasern, die eine kontrollierte Abgabe eines aktiven Mittels zur Verfügung stellen
WO2001094687A2 (en) * 2000-06-02 2001-12-13 Milliken & Company Yarns and fabrics having a wash-durable non-electrically conductive topically applied metal-based finish
GB0024884D0 (en) 2000-10-11 2000-11-22 Astrazeneca Ab Method
EP1345589B1 (en) 2000-11-29 2007-06-27 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
CA2363902C (en) 2000-12-07 2005-07-26 Warner-Lambert Company Process and system for controlled-release drug delivery
FR2826380B1 (fr) 2001-06-22 2007-03-16 Nathalie Chetboun Procede de traitement anti-acariens et anti-microbien des materiaux textiles par huile naturelle microencapsulee
US6991809B2 (en) 2001-06-23 2006-01-31 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
US7250453B2 (en) 2001-10-17 2007-07-31 Kabushiki Kaisha Sangi Anti-bacterial composite particles and anti-bacterial resin composition
GB0130608D0 (en) 2001-12-21 2002-02-06 Psimedica Ltd Medical fibres and fabrics
WO2003094888A1 (en) 2002-05-07 2003-11-20 Control Delivery Systems, Inc. Processes for forming a drug delivery device
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
WO2004043435A2 (en) 2002-11-13 2004-05-27 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JP2004195348A (ja) * 2002-12-18 2004-07-15 Akatsuki Kinzoku Kogyo:Kk 塗工シート加工装置および貼付剤
EP2143482A1 (en) 2003-02-19 2010-01-13 Natrix Separations Inc. Composite materials comprising supported porous gels
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US7803422B2 (en) 2005-05-23 2010-09-28 Appleton Papers Inc. Water-in-oil capsule manufacture process and microcapsules produced by such process
AP2007004257A0 (en) 2005-06-03 2007-12-31 Basf Ag Composition for impregnation of fibres fabrics andnettings imparting a protective activity against pests
CN1883438A (zh) 2005-06-21 2006-12-27 香港理工大学 温度响应性智能面膜及其制备方法
DE602006020063D1 (de) 2005-12-07 2011-03-24 Univ Ramot Wirkstoffabgebende verbundkörper
US8663674B2 (en) 2006-01-13 2014-03-04 Surmodics, Inc. Microparticle containing matrices for drug delivery
WO2008003043A2 (en) 2006-06-28 2008-01-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
JP2008057100A (ja) 2006-08-29 2008-03-13 Mmi-Ipco Llc 感温性且つ感湿性のスマートテキスタイル
US20090325441A1 (en) * 2006-09-08 2009-12-31 Albemarle Corporation Flame retarded textile products and a method of making the same
US8277711B2 (en) 2007-03-29 2012-10-02 E I Du Pont De Nemours And Company Production of nanofibers by melt spinning
WO2009067242A2 (en) 2007-11-20 2009-05-28 Imclone Llc Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof
US20090158492A1 (en) 2007-12-21 2009-06-25 Min Yao Quick-drying textile
WO2010065921A2 (en) 2008-12-05 2010-06-10 Lpath, Inc. Antibody design using anti-lipid antibody crystal structures
US20110142898A1 (en) 2009-12-11 2011-06-16 Jerry Fan Devices for treatment of skin disorders
US9901128B2 (en) * 2009-12-24 2018-02-27 David A. Gray Antimicrobial apparel and fabric and coverings
KR101914119B1 (ko) 2010-03-16 2018-11-02 타이탄 파머슈티컬즈 인코퍼레이티드 약물 전달용 이종 이식가능 장치
EP2555749B1 (en) 2010-04-06 2016-10-26 Allergan, Inc. Sustained-release reservoir implants for intracameral drug delivery
CN102247316B (zh) * 2011-08-16 2013-09-11 上海交通大学 一种控制药物释放的疏水涂层及其制备方法
US20140271863A1 (en) 2013-03-14 2014-09-18 Textile-Based Delivery, Inc. Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
DE102014208253A1 (de) 2014-04-30 2015-11-05 MAHLE Behr GmbH & Co. KG Abgasanlage für ein Kraftfahrzeug
KR20170016884A (ko) 2014-05-30 2017-02-14 텍스타일-베이스드 딜리버리, 인코포레이티드 약물 전달 시스템 및 관련 사용 방법
KR20170076756A (ko) 2014-10-30 2017-07-04 텍스타일-베이스드 딜리버리, 인코포레이티드 전달 시스템

Patent Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674901A (en) * 1966-07-26 1972-07-04 Nat Patent Dev Corp Surgical sutures
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
JPS4840924B1 (https=) * 1970-09-26 1973-12-04
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US6040251A (en) * 1988-03-14 2000-03-21 Nextec Applications Inc. Garments of barrier webs
US6103644A (en) * 1993-12-22 2000-08-15 Nordico Marketing Development, Inc. Impregnated matrix and method for making same
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
WO1999039705A1 (en) * 1998-02-06 1999-08-12 Woundfast Pharmaceuticals, Inc. Wound-healing composition and method
JP2000096443A (ja) * 1998-09-25 2000-04-04 Toray Ind Inc 繊維布帛およびその製造方法
JP2000212873A (ja) * 1999-01-18 2000-08-02 Nonogawa Shoji Kk 機能性繊維
CN1378445A (zh) * 1999-08-06 2002-11-06 得克萨斯系统大学评议会 药物释放生物可降解纤维植入物
JP2001097839A (ja) * 1999-09-28 2001-04-10 Shiseido Co Ltd 加齢臭抑制繊維および繊維処理剤
US20040162580A1 (en) * 2000-08-17 2004-08-19 Matthew Hain Sutures and coatings made from therapeutic absorbable glass
CN1520297A (zh) * 2001-04-26 2004-08-11 ���ߵ���Ƶϵͳ��˾ 包含复合药物(codrugs)的缓释药物传递系统
CN1612804A (zh) * 2001-12-03 2005-05-04 C·R·巴德公司 抗微生物医用器材、抗微生物聚合物涂层及其制备方法
CN1813085A (zh) * 2003-06-30 2006-08-02 宝洁公司 涂层纳米纤维网
CN100572651C (zh) * 2004-08-04 2009-12-23 考格尼斯知识产权管理有限责任公司 成品纤维和纺织品组织
CN101970560A (zh) * 2008-01-08 2011-02-09 奎克-麦德技术公司 醇可溶性的季铵聚合物消毒剂
CN102740830A (zh) * 2009-12-23 2012-10-17 普西维达公司 缓释递送装置
CN103037907A (zh) * 2010-03-31 2013-04-10 境味股份有限公司 用于嗅觉活性物质的方法、组合物和制品
WO2013033606A1 (en) * 2011-08-31 2013-03-07 The University Of Akron Coated fibers exhibiting beads-on-a-string morphology
CN103987378A (zh) * 2011-09-09 2014-08-13 阿克西亚制药有限责任公司 硅氧烷涂覆的植入物
WO2014031676A1 (en) * 2012-08-20 2014-02-27 O-Ray Pharma, Inc. Process for manufacturing drug delivery formulations
CN104582782A (zh) * 2012-08-20 2015-04-29 奥雷制药有限公司 用于制备药物递送制剂的方法
WO2014143866A1 (en) * 2013-03-15 2014-09-18 Arsenal Medical, Inc. Core-sheath fibers and methods of making and using same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREA MARTINELLI ET AL: "Release behavior and antibiofilm activity of usnic acid-loaded carboxylated poly(l-lactide) microparticles", 《EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS》 *
王刚，等: "创伤敷料的研究进展", 《中国药房》 *
许淑燕，等: "《服装材料与应用》", 31 January 2013 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4084607A4 (en) * 2019-12-31 2023-06-21 Wanka Tanka Ltd. EXTENDED RELEASE PLASTIC FORMULATION
CN114045587A (zh) * 2021-11-10 2022-02-15 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
CN114959966A (zh) * 2022-07-15 2022-08-30 苏州赛恩环境科技有限公司 一种内注甲醛清除剂的纤维线生产设备及方法

Also Published As

Publication number Publication date
JP2018503598A (ja) 2018-02-08
US11690808B2 (en) 2023-07-04
US9669012B2 (en) 2017-06-06
CA3003397A1 (en) 2016-05-06
KR20170076756A (ko) 2017-07-04
MX2017005399A (es) 2017-07-26
US20190038568A1 (en) 2019-02-07
AU2015339203B2 (en) 2020-12-24
US20230338301A1 (en) 2023-10-26
US20190105283A1 (en) 2019-04-11
WO2016069898A1 (en) 2016-05-06
US20200390720A1 (en) 2020-12-17
EP3212173A4 (en) 2018-06-20
AU2015339203A1 (en) 2017-04-20
BR112017007942A2 (pt) 2017-12-19
US20160120986A1 (en) 2016-05-05
US11633366B2 (en) 2023-04-25
US20170231919A1 (en) 2017-08-17
US10799464B2 (en) 2020-10-13
JP6896625B2 (ja) 2021-06-30
US20230255895A1 (en) 2023-08-17
EP3212173A1 (en) 2017-09-06

Similar Documents

Publication Publication Date Title
CN107205956A (zh) 输送系统
US20140271863A1 (en) Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
CN106659287B (zh) 美容片及其制造方法
EP0355536B1 (de) Flexibler, hydrophiler Gelfilm, Verfahren zu seiner Herstellung und Verwendung
CA2386810C (en) Electrospun skin masks and uses thereof
US11717657B2 (en) Dermal adhesive patch
CA2594408A1 (en) Device and method for treatment of dermatomycosis, and in particular onychomycosis
BRPI0910382A2 (pt) artigo de manufatura, método para a obtenção de micropartículas, método para preparação de um artigo de manufatura, método para liberar um ingrediente ativo a um indivíduo, método para liberar um agente terapêutico a um indivíduo, método para liberar um agente cosmético a um indivíduo, micropartícula para liberar um ingrediente ativo, formulação para obtenção de micropartículas, veículo de aplicação para transferência de micropartículas a um substrato
EP3569260A1 (en) Non-woven fabric bandage and a method for the production of a non-woven fabric bandage
CN106400308A (zh) 一种自芳香天然抗菌除臭非织造布及其应用
CN106283406A (zh) 一种自芳香非织造布及其应用
KR20170077658A (ko) 복합 나노섬유를 이용한 소프트 나노섬유 마스크 시트 및 이의 제조방법
WO1998029143A1 (de) Extrem flexibles, dermal oder transdermal wirkendes pflaster und verfahren zu seiner herstellung
US20220401376A1 (en) Delivery systems for release of active compounds
KR20110109250A (ko) 수성/비수성 약물전달에 적용 가능한 고분자 혼합물을 이용한 고분자 수성 혼합용액으로 만들어진 필름 형성제 조성물 및 그의 제조방법
US20220175691A1 (en) Delivery systems for release of active compounds
US20230404935A1 (en) Delivery systems
KR101696275B1 (ko) 색조화장이 가능한 나노케어 스팟패치 및 그 제조방법
JPH08226078A (ja) 抗菌剤含有ナイロン繊維およびその製造法
JPH03223213A (ja) アルギン酸塩含水ゲルシートの製造方法
KR20180107991A (ko) 수용성 고분자 및 비수용성 고분자가 복합된 나노섬유 마스크 시트
CZ36370U1 (cs) Prostředek pro aplikaci na kůži s antioxidačními účinky
JP2022023152A (ja) 外用薬
US20130236521A1 (en) SnF2 APPLICATIONS, METHODS AND RELATED FORMULATIONS
HK1253204A1 (en) Core-shell nanofibrous membranes, the method of fabricating thereof, and related polymer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170926

RJ01 Rejection of invention patent application after publication